roypounder.apt

@APandT new papers in AP&T, summaries free-to-view. 2023 Impact Factor is 6.6, ranking AP&T 18/97 for journals in Gastroenterology & Hepatology.

[roypounder.apt @APandT]

"Development and Prospective Validation of a Machine Learning-Based Mobile Application (CROHN'S AID) for Differentiating Crohn's Disease From Intestinal Tuberculosis in Tuberculosis-Endemic Regions" is now published at https://t.co/5Bddznmaqk
#GItwitter #Crohns #IBD

[roypounder.apt @APandT]

Available to read 'open access' via https://t.co/ul0nqvEzKo "Medication Use and Risk of Microscopic Colitis: A Propensity-Matched Analysis of US Adults ≥ 50 Years (2014–2024)"
#GItwitter #microscopiccolitis #NSAIDs #PPIs #SSRIs

[roypounder.apt @APandT]

Read open access via https://t.co/IymsLK2Yi0 "Carriage of the Laboratory of Genetics and Physiology Protein 2 Q425R Variant Reduces Liver Disease Severity in European Patients With Chronic Hepatitis Delta"
#livertwitter #HDV #HBV #HCC

[roypounder.apt @APandT]

Read "Clinical Trial: Randomised Placebo-Controlled Trial of Methylcellulose and Psyllium Gels on Inulin-Induced Colonic Gas" by Dellschaft et al via https://t.co/BzeIBv23ne
#GItwitter #colonicgas #IBS

[roypounder.apt @APandT]

1st October 2026 issue available to view via https://t.co/NWqkWBBuIm

#GItwitter #livertwitter #MASLD #coeliac #AIH #HCC #EoE #pancreas #ulcerativecolitis #IBD

[roypounder.apt @APandT]

Read via https://t.co/HcfRsb5ywB "Risk of Coeliac Disease After Immune Checkpoint Inhibitor Exposure in Patients With Cancer"
#GItwitter #coeliacdisease #ICIs

[roypounder.apt @APandT]

"Pharmacokinetic and Pharmacodynamic Variability Predict Late Events After Paediatric Liver Transplantation: Derivation and External Validation of a Landmark Risk Score" by Tang et al available to read via https://t.co/Ufyk8aL7mY
#livertwitter

[roypounder.apt @APandT]

Read "Long-Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD-ALD Prediction Index" just published online at https://t.co/GQ2D7faYVX
#livertwitter #MetALD

[roypounder.apt @APandT]

In a propensity score–matched real-world study, PPI exposure was associated with increased occurrence of gastric neuroendocrine neoplasms, supporting careful long-term PPI prescribing in patients with autoimmune gastritis. Read via https://t.co/mTR9vkbHRa
#GItwitter #gastricNET

[roypounder.apt @APandT]

Read via https://t.co/td8PjWmoKM "Intestinal Ultrasound Predicts Primary Non-Response and Maintenance Relapse in Upadacitinib-Treated Active Crohn's Disease: A Multicenter, Prospective Cohort Study"
#IBD #GItwitter

[roypounder.apt @APandT]

"Anti-Integrin αvβ6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A Prospective Cross-Sectional Study" - read the full paper via https://t.co/NThN0OPZs8
#GItwitter #IBD

[roypounder.apt @APandT]

"Review Article: Fibrosis Reversal in Metabolic Dysfunction-Associated Steatohepatitis—The Promise of Emerging Therapeutics" - read the full review article 'open access' via https://t.co/I3UqDWVK4m
#MASH #livertwitter #review

[roypounder.apt @APandT]

"Review Article: Immune Effector Cell-Mediated Enterocolitis Following CAR-T Cell Therapy—Clinical Features, Pathophysiology and Management" by Damianos et al available to read 'open access' via https://t.co/SC5aaykQdM
#GItwitter

[roypounder.apt @APandT]

"Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study" by Caballero et al is now available to read open access via https://t.co/wRXhkKrFfc
#GItwitter #IBD

[roypounder.apt @APandT]

Read open access via https://t.co/E4lvkKOpCP
"Screen-Detected Coeliac Disease in a Nationally Representative Cohort: Health Indicators, Long-Term Outcomes and Mortality"
#coeliac #GItwitter

[roypounder.apt @APandT]

"Meta-Analysis: Prevalence of Non-Helicobacter pylori, Non-NSAID Peptic Ulcer Disease" by Watanabe et al. Read 'open access' via https://t.co/6lqFQsplmX
#GItwitter #pepticulcer

[roypounder.apt @APandT]

"Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction-Associated Steatohepatitis—Reanalysis of Fibrosis Stage 2–3 Subset" by Mironova et al. Read at https://t.co/Uhcm9jIdjM
#liver #resmetirom #MASH

[roypounder.apt @APandT]

"Clinical Trial: Multi-Strain Probiotic Improves Bile Acid Profile, Microbiome, and Metabolomic Parameters in Patients With History of Bile Acid Malabsorption—A Randomized, Controlled Trial" by Damianos JA, et al. https://t.co/hckOe4ELDb

[roypounder.apt @APandT]

Read open access at https://t.co/XSzPd3olih "Review Article: Accelerating Coeliac Disease Clinical Trials—Beyond Celiac Meeting With Industry, Academics, Patients and the FDA" by Fahey et al.

[roypounder.apt @APandT]

AP&T's 2025 IF is 6.8!